GlaxoSmithKline has withdrawn a Thai patent application for an AIDs drug
following public pressure. So reports LifeStyleExtra. It has not given the reason, though campaigners claim it is because the invention combined formerly known drugs in a way that was not patentable.
The IPKat reckons its hard to know the reason why, but the effect is the same.
Good luck to all those students taking the London LLM IIP exam tomorrow.